Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (10)

2024

  1. Efficacy and Safety of Calcifediol in Young Adults with Vitamin D Deficiency: A Phase I, Multicentre, Clinical Trial—POSCAL Study

    Nutrients, Vol. 16, Núm. 2

2021

  1. Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 4, pp. 270-276

2018

  1. Position statement for the management of comorbidities in psoriasis

    Journal of the European Academy of Dermatology and Venereology, Vol. 32, Núm. 12, pp. 2058-2073

2015

  1. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis

    Maturitas, Vol. 82, Núm. 4, pp. 402-410

2013

  1. Comparative effects of teriparatide and risedronate in glucocorticoid- induced osteoporosis in men: 18-month results of the EuroGIOPs trial

    Journal of Bone and Mineral Research, Vol. 28, Núm. 6, pp. 1355-1368

  2. Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

    Osteoporosis International, Vol. 24, Núm. 12, pp. 2971-2981

2012

  1. Risk factors for prediction of inadequate response to antiresorptives

    Journal of Bone and Mineral Research, Vol. 27, Núm. 4, pp. 817-824

2008

  1. Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: The Observational Study of Severe Osteoporosis (OSSO)

    Osteoporosis International, Vol. 19, Núm. 4, pp. 493-501

2006

  1. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: The Observational Study of Severe Osteoporosis (OSSO)

    QJM, Vol. 99, Núm. 8, pp. 531-543

2004

  1. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study

    Clinical Therapeutics, Vol. 26, Núm. 2, pp. 245-256